Preclinical evaluation of biomarkers for ovarian cancer detection and monitoring for disease recurrence

被引：0
|
作者：
Havrilesky, Laura J.
Whitehead, Clark
Rubatt, Jennifer
Cheek, Robert L.
Groelke, John
He, Qin
Malinowski, Douglas P.
Fischer, Timothy J.
Berchuck, Andrew
机构：
[1] Duke Univ, Durham, NC USA
[2] TriPath Oncol Inc, Durham, NC USA
来源：
GYNECOLOGIC ONCOLOGY | 2007年 / 104卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S12 / S12
页数：1
相关论文
共 50 条
  • [41] Identification of novel biomarkers for early detection of ovarian cancer
    Szabo, Linda A.
    Khatri, Purvesh
    Liu, Xiaodan
    Hu, Zhongkai
    Ling, Bruce
    Butte, Atul J.
    CLINICAL CANCER RESEARCH, 2013, 19
  • [42] Plasmalogens, a new class of biomarkers for ovarian cancer detection
    Shan, L.
    Davis, L.
    Hazen, S. L.
    CLINICAL CHEMISTRY, 2007, 53 (06) : A110 - A110
  • [43] Identification of candidate epigenetic biomarkers for ovarian cancer detection
    Huang, Yi-Wen
    Jansen, Rachel A.
    Fabbri, Enrica
    Potter, Dustin
    Liyanarachchi, Sandya
    Chan, Michael W. Y.
    Liu, Joseph C.
    Crijns, Anne P. G.
    Brown, Robert
    Nephew, Kenneth P.
    Van Der Zee, Ate G. J.
    Cohn, David E.
    Yan, Pearlly S.
    Huang, Tim H. -M.
    Lin, Huey-Jen L.
    ONCOLOGY REPORTS, 2009, 22 (04) : 853 - 861
  • [44] Circulating epigenetic biomarkers for the early detection of ovarian cancer
    Gooden, Gerald C.
    Legendre, Christophe
    Spillman, Monique
    Goel, Ajay
    Salhia, Bodour
    CANCER RESEARCH, 2018, 78 (13)
  • [45] Urinary biomarkers for the detection of ovarian cancer: a systematic review
    Owens, Gemma L.
    Barr, Chloe E.
    White, Holly
    Njoku, Kelechi
    Crosbie, Emma J.
    CARCINOGENESIS, 2022, 43 (04) : 311 - 320
  • [46] Early detection of ovarian cancer using group biomarkers
    Tchagang, Alain B.
    Tewfik, Ahmed H.
    DeRycke, Melissa S.
    Skubitz, Keith M.
    Skubitz, Amy P. N.
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (01) : 27 - 37
  • [47] Preclinical Evaluation of Artesunate as an Antineoplastic Agent in Ovarian Cancer Treatment
    McDowell, Anthony, Jr.
    Hill, Kristen S.
    McCorkle, Joseph Robert
    Gorski, Justin
    Zhang, Yilin
    Salahudeen, Ameen A.
    Ueland, Fred
    Kolesar, Jill M.
    DIAGNOSTICS, 2021, 11 (03)
  • [48] BRCAness profile of ovarian cancer predicts disease recurrence
    Pejovic, T.
    Li, H.
    Syriac, S.
    Zhang, W.
    Mhawech-Fauceglia, P.
    GYNECOLOGIC ONCOLOGY, 2011, 121 (01) : S17 - S17
  • [49] Shortcomings in the evaluation of biomarkers in ovarian cancer: a systematic review
    Olsen, Maria
    Ghannad, Mona
    Lok, Christianne
    Bossuyt, Patrick M.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2020, 58 (01) : 3 - 10
  • [50] Detection and analysis of multiple biomarkers in ovarian cancer: clinical significance in diagnosis, treatment, and prognosis evaluation
    Ji, Rui
    Li, Yong
    He, Chenyun
    Zhu, Xinghua
    He, Aiqin
    Lu, Yunyan
    GLAND SURGERY, 2020, 9 (06) : 2175 - 2186
12345